Here are four insights:
1. Forty-one health officials from different state and health departments submitted a petition to the FDA on Feb. 22.
2. The petition’s advocates say medical professionals have both a moral and professional obligation to be transparent about the risks and exercise caution when prescribing patients the medications.
3. A recent study found benzodiazepine overdoses accounted for nearly 33 percent of the 23,000 deaths attributed to prescription drug overdoses in the United States in 2013. American Journal of Public Health published the study last week.
4. Experts claim when the drugs are taken together, they severely depress the respiratory systems, causing some patients to stop breathing. Health officials want the FDA to include a warning, which says using the drugs simultaneously “reduces the margin of safety for respiratory depression and contributes to the risk of fatal overdose, particularly in the setting of misuse.”
More spine news:
5 thoughts on outcomes measurements for spinal trauma patients
Spine surgeon leader to know: Dr. James Kang of Brigham and Women’s Hospital
10 spine, neurosurgeons on the move in January 2016
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
